NSCLC and HER2: Between Lights and Shadows-Reference-Cited by-同舟云学术

NSCLC and HER2: Between Lights and Shadows

Published:2014-12 Issue:12 Volume:9 Page:1750-1762
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ricciardi Giuseppina Rosaria Rita,Russo Alessandro,Franchina Tindara,Ferraro Giuseppa,Zanghì Mariangela,Picone Antonio,Scimone Antonino,Adamo Vincenzo

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference109 articles.

1. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

2. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic and Molecular Characteristics of HER2 (ERBB2)-Altered Non–Small Cell Lung Cancer: Implications for Precision Medicine;Modern Pathology;2024-06

2. Novel therapeutic strategies for rare mutations in non-small cell lung cancer;Scientific Reports;2024-05-05

3. Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis;Journal of Cancer Research and Clinical Oncology;2024-01-27

4. Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers;International Journal of Molecular Sciences;2024-01-15

5. HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies;Life;2023-12-29